理邦儀器(300206.SZ)第三季度淨利潤預降55%-65%
格隆匯10月12日丨理邦儀器(300206.SZ)公佈，預計2021年前三季度實現營業收入12.32億元-13.27億元，同比下降30%-35%；歸屬於上市公司股東的淨利潤23529.82萬元-26709.53萬元，同比下降58%-63%；扣除非經常損益後的淨利潤19789.83萬元-22788.29萬元，同比下降62%-67%。
其中，第三季度實現營業收入35840.91萬元-38930.64萬元，同比下降37%-42%；歸屬於上市公司股東的淨利潤5710.06萬元-7341.5萬元，同比下降55%-65%；扣除非經常損益後的淨利潤3996.07萬元-5594.5萬元，同比下降65%-75%。
業績變動原因如下： 1、報吿期內，公司整體營收較去年同期有所下降，除監護產品線外，超聲產品線、心電產品線、婦幼產品線、體外診斷產品線及智慧醫療業務均實現正向增長。2020年前三季度，由於疫情在全球範圍內爆發，與抗疫直接相關的監護產品線銷售出現爆發式增長，帶動當期整體營收基數變大。本報吿期內，隨着全球疫情緩解，監護產品的市場銷售已逐步恢復至正常狀態，進而使得本報吿期內的整體營收有所下降。
2020年受疫情影響，營收異常增長，若以本報吿期整體營收數據與2019年前三季度相比，預計增速為50.29%-61.85%，複合增長率仍維持在30%左右，保持着快速增長態勢。
2、報吿期內，公司繼續以理邦云為業務核心，通過融合雲計算、物聯網、人工智能、5G 等新型技術及理念，對現有信息化綜合解決方案持續進行優化，目前已推出的方案包括：智慧電生理綜合解決方案、智慧監護信息化綜合解決方案、智慧婦幼一體化平台解決方案、智慧胸痛信息化綜合解決方案、智慧心電網絡信息化綜合解決方案及智慧檢驗信息化綜合解決方案。特別是智慧心電網絡信息化解決方案，在基層醫療和等級醫院中滲透率穩步提高，未來有望帶動公司整體智慧醫療業務實現快速發展。
3、報吿期內，公司非經常性損益對淨利潤影響預計為3600萬元左右，主要為政府補助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
